Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...11121314151617181920...
CompanyDrug NameStatusIndication Group
Genentech Rituxan in Phase IICardiovascular system
Biogen Idec Rituxan Approved in USAAntineoplastic & immunomodulating agents
Biogen Idec Rituxan Approved in USAAntineoplastic & immunomodulating agents
Genentech Rituxan Failed in Phase II/IIINervous system
Johnson & Johnson Risperdal Approved in USANervous system
Johnson & Johnson Risperdal Submitted for approval in USANervous system
Johnson & Johnson Risperdal Approved in USA and CanadaNervous system
Johnson & Johnson Risperdal discontinuedNervous system
Alkermes Risperdal Submitted USNervous system
La Jolla Riquent Approved in USAAntineoplastic & immunomodulating agents
ActivBiotics Rifalazil in Phase IICardiovascular system
ActivBiotics Rifalazil in Phase IIICardiovascular system
MediGene AG RhuDex in Phase IIMusculoskeletal system
Active Biotech RhuDex in Phase IIMusculoskeletal system
ZymoGenetics rhThrombin accomplished Phase IIIBlood & blood forming organs
EntreMed rhEndostatin in Phase IIAntineoplastic & immunomodulating agents
ZymoGenetics rFactor XIII in Phase IBlood & blood forming organs
Bristol-Myers Squibb Reyataz Approved in USAAnti-infectives for systemic use
Fresenius Biotech rexomun accomplished Phase IAntineoplastic & immunomodulating agents
Epeius Biotechnologies Rexin-GTM in Phase IAntineoplastic & immunomodulating agents
...11121314151617181920...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.